Adalimumab trough levels of 4.0 mg/L or higher among patients with RA were linked to greater treatment response and ...

Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...

The word “arthritis” describes pain, stiffness, and swelling in the joints. It can be a bit of a nuisance or extremely ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...

The study suggests that this gut bacterium may drive the immune response leading to RA in people who are genetically or ...

Nurse-led care effectively reduces disease activity and improves self-efficacy in patients with rheumatoid arthritis, ...

RA treatment aims to decrease inflammation, which decreases symptoms (pain/discomfort and stiffness), and lessens the risk of joint damage. By limiting joint damage, disability is reduced. The primary ...

Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid ...

High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.

Anemia is prevalent among patients with rheumatoid arthritis, according to study findings published in Cureus.

Rheumatoid arthritis (RA) is associated with a higher rate of ... muscle and bone diseases. Various treatments are available. Non-pharmacological treatment includes physical therapy, orthoses ...